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Summary
Introduction: Chronic radiation proctitis is often
associated to radiotherapy for treatment of pelvic
cancer. The most common side effect of this
pathological condition is rectal bleeding but
despite the great number of clinical approaches
and techniques that have been employed no
consensus for the management of it is available.
Although prospective randomized trials about
hemorrhagic radiation proctitis are still lacking,
endoscopic approach delivering an Argon Plasma
Coagulation (APC) seems to be a successful and
available option. Patients and Methods: Sixteen
patients suffering from post-radiotherapy rectal
bleeding were followed. In the nine cases
presenting a rectum ulcerative colitis (RUC) like
endoscopic picture a 5-ASA therapeutic
approach was chosen initially, followed by an
Riassunto
Introduzione: La proctite cronica è spesso asso-
ciata a terapia radiante per il trattamento dei tu-
mori della zona pelvica. La complicanza più co-
mune della proctite è il sanguinamento rettale
ma, nonostante le numerose tecniche utilizzate
nel trattamento di tale patologia, nessuna di esse
viene universalmente ritenuta la migliore. Sebbe-
ne non esistano ancora trials randomizzati sulla
proctite associata a radioterapia, l’Argon Plasma
Coagulation (APC) per via endoscopica sembra
un’alternativa di facile realizzazione e successo.
Pazienti e Metodi: Dei sedici pazienti affetti da
sanguinamento rettale conseguente a radiotera-
pia oggetto dello studio, nove manifestavano un
quadro endoscopico caratteristico della rettocoli-
te ulcerosa (RCU), sette presentavano un quadro
clinico più lieve con sole aree di telangectasia. I
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Introduction
The treatment of pelvic malignancies, including
prostate cancer and cancer of cervix and uterus, is
based on ionizing radiations which cause submu-
cosal tissue injury to the rectal wall leading to
chronic radiation proctitis (Fig. 1). Its development
depends on the modalities of radiotherapy adminis-
tration as well as other factors including previous
proctocolitis, history of smoking, diabetes mellitus.
There is no agreement about the exact pathophysi-
ology of radiation proctitis but the currently
accepted hypothesis proposes a combination of radi-
ation-induced ischemia and fibrosis (1).
Rectal bleeding is the main sign of radiation proc-
titis and it is generally moderate but it may also be
severe causing hemodinamic disturbances which
need specific therapeutic management (blood trans-
fusion). Other side effects such as diarrhea, inconti-
nence, pain, tenesmus, rectovaginal fistula, may also
occur compromising the quality of life.
The endoscopic aspect of radiation proctitis is
characterized by the presence of more or less dense
telangiectasia dispersed locally or in a diffuse
manner over the rectal mucosa which bleeds easily,
particulary at introduction of the endoscope. The
lesion begins at the dentate line and it may localize
to one part of the rectum or may extend to the
sigmoid. Interestingly it has been proposed that this
chronic microvasculature injury could be partially
determined by an alteration of the thrombomodulin
expression in endothelial cells which is a conse-
quence of radiotherapy (2).
A large number of treatment has been proposed
for hemorrhagic radiation proctitis. Pharmacological
agents used for this purpose (oral, topic or mixed)
are often unsatisfactory, with partial recovery and
short term relapses. Several case series have proved
38
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APC treatment of areas of telangectasias. The
other cases, presenting only areas of telangec-
tasias, were treated only with APC. Results: 5-
ASA therapy led to an improvement of inflam-
mation state related to RUC but recurrence of
rectal bleeding caused by telangectasias was
observed. In these cases an additional APC treat-
ment gave a total remission of the problem. Also
in the other cases, presenting only areas of
telangectasias, a remission of rectal bleeding was
achieved through APC application. Conclusions:
In the cases of radiation proctitis characterized
by a severe compromission of rectal mucosa
integrity an anti-inflammatory pharmacological
therapy is necessary but not sufficient to abro-
gate rectal bleeding which is often caused by the
presence of areas of telangectasias. In these cases
a remission of the problem could be achieved
through a combination of anti-inflammatory
therapy (5-ASA) and APC. Eur. J. Oncol., 17 (1),
37-41, 2012
Key words: Argon Plasma Coagulation, hemor-
rhagic radiation proctitis, anti-inflammatory
therapy in ulcerative colitis
pazienti del primo gruppo sono stati trattati ini-
zialmente con 5-ASA e successivamente sottoposti
ad APC nel tentativo di eliminare le aree di te-
langectasia. I pazienti del secondo gruppo sono
stati sottoposti solamente ad APC. Risultati: Il
trattamento con 5-ASA ha determinato un mi-
glioramento dello stato infiammatorio correlato
alla RCU ma la scomparsa del sanguinamento
rettale si è osservato solo in seguito ad APC. Que-
sta è risultata risolutiva anche nei pazienti che
mostravano solamente aree di telangectasia. Con-
clusioni: Nei casi di proctite post-radioterapia as-
sociati ad una severa compromissione dell’inte-
grità della mucosa rettale una terapia farmacolo-
gica antinfiammatoria è necessaria ma non suffi-
ciente ad eliminare il sanguinamento rettale cau-
sato dalla presenza di aree di telangectasia. In
questi casi la completa remissione della patologia
può essere ottenuta aggiungendo alla terapia an-
tinfiammatoria il trattamento con APC. Eur. J.
Oncol., 17 (1), 37-41, 2012
Parole chiave: Argon Plasma Coagulation, procti-
te emorragica dopo radioterapia, terapia antin-
fiammatoria nella retto colite ulcerosa
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disappointing results with topical or oral
sulfasalazine, 5-aminosalicylic acid (5-ASA) and
corticosteroids (3-5).
A certain degree of efficacy has been reported
with topical formaldehyde and topical or oral sucral-
fate (6-8).
Development of new endoscopic procedures has
led to a higher rate of therapeutic success and longer
period of symptomatic control. The goal of endo-
scopic therapy is to ablate the angioectasia with a
resultant improvement in the severity and frequency
of rectal bleeding. Both laser and mono or bipolar
electrocoagulation have been considered to be the
most effective methods of treatment for these
patients. However both techniques are associated
with potential morbidity derived from the difficulty
of assessing the depth of the termal effect on the
rectal wall.
APC is a relatively new method of non-contact
elettrocoagulation well suited for hemostasis of large
bleeding areas. In this paper we describe our experi-
ence in the treatment of patients suffering from radi-
ation-induced proctitis with both pharmacological
therapy (5-ASA) and APC.
Patients and Methods
From January 2005 to March 2008 we followed, at
the service of our Endoscopy Unit within the Depart-
ment of Oncology, sixteen patients, eleven males
and five females aged between 41 and 78 years
(range 62.3) who suffer from post-radiotherapy
rectal bleeding. Eleven out of the sixteen patients
suffer from prostate cancer, three from endometrial
cancer and two from cervical cancer.
All patients underwent total colonscopy to
exclude other causes of bleeding. The equipment
used were standard colonscopes: Olympus CF 100
videoendoscope, connected to Olympus CV 100
videoprocessor, an APC equipment with APC probe
with external diameter of 2 mm and internal diam-
eter of 1.5 mm, argon delivery unit (ERBE Argon
Plasma Coagulator ICC 200, ERBE Electromedizin,
Tubingen, Germany). The argon gas flow was set
between 1.5 and 2 l/min at 40-60 W power.
Five patients had been treated at other divisions
and eleven were at the first observation. Nine out of
other eleven patients showed a RUC-like endoscopic
picture with intensely hyperemic mucosa, rough,
crumbly bleeding involving the entire wall and not
extending more than 25-30 cm from the anal. In the
remaining two cases there was a similar picture to
that found in the other, but more nuanced, and pres-
ence of numerous telangiectasias in areas free from
erosion was observed.
The first nine cases were treated with 5-ASA, in
the other two cases APC therapy was started imme-
diately. The nine patients initially treated with 5-
ASA were examined after two weeks. The RCU-like
picture disappeared but we observed areas of telang-
iectasia which were treated with APC.
In the five cases showing recurrent episodes and
which involve other treatments at other centers, we
found endoscopically areas of telangiectasia which
were treated with APC.
Results
All patients underwent a careful follow-up every
three months. Patients who began treatment with 5-
ASA had a rapid remission of symptoms and
improvement in the inflammation state. Some of
39
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Fig. 1. Ulceration of anterior rectal wall following radio-
therapy
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these, however, during the follow-up showed a new
bleeding associated to telangiectasias (Fig. 2)
without mucosal inflammation. In these cases APC
was the therapeutic approach (Fig. 3).
Rapid disappearence of rectal bleeding was
achieved in patients who underwent APC therapy
since the first session of treatment. The endoscopic
coagulation performed every 6-12 months was able
to easily treat other telangiectasias eventually arisen.
All patients showed no symptoms and negative
endoscopic picture during a two years follow-up and
six months after the last control.
Discussion
APC shows many advantages (9). The unit is
compact, mobile and easy to maintain, it is simple to
perform and easily learnt. The non-contact nature of
application allows large areas to be treated rapidly,
in contrast to contact thermal techniques such as
heater probe or multipolar diathermy. The technique
creates less smoke than laser therapy, allowing better
views and shorter treatment time. The favourable
features of APC are related to its predictable depth of
tissue destruction and preferential arcing to areas of
non dessicated tissue when it is utilized in a non-
contact fashion (10).
APC has been used in gastrointestinal endoscopy
since 1994 (11). Three years later were reported
preliminary results about APC treatment of radia-
tion-induced proctitis (12).
From this preliminary experience the efficacy and
safety of APC have been suggested in several case
series (13-17).
The results in this study provide further data about
the efficacy, safety and well-tolerance of APC in
chronic rectal bleeding related to radiation proc-
topathy; another interesting approach, reported in
literature, consists of bipolar coagulation (18).
No complications were encountered in this series.
All the patients were without disease after two years
of follow-up.
In the patients with an endoscopic presentation
like-RUC the initial use of oral 5-ASA obtained a
rapid remission of the clinical manifestation and the
endoscopic aspect. The subsequent use of APC over
rectal telangiectasia led to a complete and persistent
clinical remission.
40
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Fig. 2. Post-radiotherapy proctitis. Rectal bleeding was
treated with APC. During the procedure the probe is not to
in close contact with the mucosa allowing the argon gas to
perform its cauterizing effect when burned
Fig. 3. Post-radiotherapy proctitis with rectal bleeding. Cau-
terization of bleeding lesions was achieved through APC
treatment
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Conclusions
The authors believe that the post-radiotherapy
rectal bleeding is caused initially by inflammation but,
in the later steps, the formation of areas of telangiec-
tasia reminiscent of angiodysplasia of the colon plays
a crucial rôle; therefore elimination of areas of telang-
iectasia, using APC therapy, seems to be successful
and free of complicances in the treatment and preven-
tion of recurrent episodes of rectal bleeding.
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